New Media Offers Cost-Efficient Ways to Reach and Engage Targets

Manhattan ResearchOver 145 million U.S. adults use the Internet to research health information, according to pharmaceutical and healthcare market research company Manhattan Research. The company has just released Cybercitizen Health v8.0, a multi-client study and strategic advisory service focused on how consumers use media and technology for health information and its impact on treatment and product decisions.

"Tough economic times cause marketers to be held more accountable for spending and measurement," said Mark Bard, Manhattan Research President, "With over 145 million consumers online for health, new media offers cost-effective ways to reach and engage target audiences. In order to efficiently allocate budgets, companies must understand the rapidly evolving health media channels and how consumers are using them to complement and replace the traditional offline health system."

Manhattan Research will host a webinar event, "Is TV Dead? How the New New Media Changes Pharmaceutical DTC Advertising," on October 14th at 11am EST and October 16th at 3pm EST. The webinar will help pharmaceutical and healthcare marketers understand the optimal media mix in the face of an uncertain economy. Meredith Abreu Ressi, VP of Research, will overview key market data and trends from CybercitizenÒ Health v8.0. Register here: https://manhattanresearch.webex.com.

Webinar Topics:

  • Evolving Consumer Use of TV and Video

How can marketers play the consumer shift to online video for entertainment and information to their advantage?

  • Going Mobile for Health

What are the latest trends and strategies for reaching a growing market of consumers using their mobile phones to find health info?

  • Engaging in Health 2.0

How are patients and caregivers using online communities, widgets, blogs, and wikis, and what should companies and agencies be doing about it? This topic is especially relevant for marketers looking to reach those most active in health social media, like cancer and fibromyalgia patients.

  • The Online Health Shake Up

What will the recent Waterfront Media-Revolution Health merger mean for pharma companies and their media partners? How can marketers stay ahead of the curve? Will sites eventually serve as a conduit linking physicians with their patients?

  • The Doctor…err…the Internet will See You Now

How does the decrease in consumer reliance on the physician affect your brand?

About Cybercitizen® Health v8.0
Cybercitizen® Health was fielded in Q3 2008 among 8,714 U.S. adults (ages 18+). In addition to the data, clients receive strategic deliverables including research reports, client briefings, and access to the Manhattan Research analyst team to answer specific questions. For topics and available therapeutic segmentations (80+), visit http://www.manhattanresearch.com/cch.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

Most Popular Now

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Roche announces the European Commission approval o…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission (EC) has approved Xofluza® (baloxavir marboxil) in children aged one year and above for the trea...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

A soybean protein blocks LDL cholesterol productio…

A protein in soybeans blocks the production of a liver enzyme involved in the metabolism of triglycerides and low-density lipoprotein, scientists found in a recent study...

Discovery of anti-cancer chemistry makes skullcap …

The evolutionary secrets that enable the medicinal herb known as barbed skullcap to produce cancer fighting compounds have been unlocked by a collaboration of UK and Chin...